UK Government to address the underlying biology of aging

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

UK’s Life Sciences Vision aims to build on pandemic response and deliver life-changing innovations to patients with 10-year strategy to solve some of the biggest healthcare problems of our generation.

The UK is hoping to build on the response of its life sciences sector to COVID-19 to accelerate the delivery of life-changing innovations to patients; the response will form part of the blueprint for the Government’s new UK Life Sciences Vision.

Longevity.Technology: The UK’s Life Sciences Vision was co-developed with businesses and experts in the field, and it sets out a mission-led approach with bold ambition for the next decade. The UK is keen to ensure scientific excellence, partnered with the dynamism of industry, is replicated to assist the NHS in solving the most pressing health challenges of our generation now and in the future.

The Vision outlines 7 critical healthcare missions that government, industry, the NHS, academia and medical research charities will work together on at speed to solve – from addressing aging to tackling dementia.

These missions will focus on preventing, diagnosing, monitoring and treating disease early, using innovative clinical trials to develop breakthrough products and treatments quickly to help save lives, and accelerating the development and adoption of new drugs, diagnostics, medical technology and digital tools.

The missions are:

  • Accelerating the pace of studies into novel dementia treatment
  • Enabling early diagnosis and treatments, including immune therapies such as cancer vaccines
  • Sustaining the UK’s position in vaccine discovery, development and manufacturing
  • Treatment and prevention of cardiovascular diseases and its major risk factors, including obesity
  • Reducing mortality and morbidity from respiratory disease in the UK and globally
  • Addressing the underlying biology of aging
  • Increasing the understanding of mental health conditions, including work to redefine diseases and develop tools to address them

Prime Minister Boris Johnson said: “We are indebted to the ingenuity of UK life sciences and its pioneers, with the discovery of the Oxford-AstraZeneca vaccine and the seamless collaboration between our scientists, industry, regulators and NHS saving millions of lives during the pandemic.

“We must make sure this is the norm and use this new way of working to search for life-changing breakthroughs against diseases such as cancer, dementia and obesity, as we have done with COVID. That’s why we are setting out our new Life Sciences Vision to bottle the formula we have developed to tackle COVID and improve health outcomes for patients across the board in the UK, and secure jobs and investment in the process as we build back better [1].”

Emulating success

The Vision looks to emulate the successes of the UK Vaccines Taskforce – harnessing private sector expertise and streamlining bureaucracy to allow industry leaders to tackle future healthcare challenges at speed and at risk – with the aim of changing people’s lives for the better.

Interview with Sir John Bell for Longevity Technology
Professor Sir John Bell, University of Oxford, Co-chair, External Advisory Group

The Government hopes the Vision will benefit from what it calls “new regulatory freedoms and opportunities now that we have left the European Union”, claiming that the Medicines & Healthcare products Regulatory Agency (MHRA) will be able to act as an independent, agile, sovereign regulator, with a focus on getting vaccines, drugs, and technologies to patients as safely and quickly as possible.

Addressing the most pressing healthcare challenges of our generation now and in the future will be an important part of the government’s levelling up agenda, helping to reduce health inequalities and improving outcomes for patients in every corner of the UK.

Professor Sir John Bell, University of Oxford, Co-chair of the External Advisory Group said: “There is now a race to become one of the world leaders in the growth of Life Sciences as an industrial sector. We have demonstrated throughout the COVID pandemic how effective we can be when industry, academia, government, charities and the NHS all work together. If we continue to work as effectively together we are very likely to bring great benefits to patients and also to grow our economy at pace.”

Investing in life sciences

The government has today also launched its Life Sciences Investment Programme, a £200 million government investment that will unlock the potential of innovative UK life sciences companies so that they can grow their operations and create high-skilled jobs in the UK.

The programme will leverage further private sector investment and support the development of a world leading UK life sciences venture capital ecosystem. The investment will be delivered through British Patient Capital, part of the government-owned British Business Bank, which will allocate the £200 million to specialist funds.

In a further boost to the sector, British Patient Capital has recently agreed a collaboration with Abu Dhabi’s Mubadala Investment Company, one of the world’s leading sovereign investors. Under this partnership, facilitated by the Office for Investment, Mubadala has committed to invest £800 million in the UK life sciences industry and will work with British Patient Capital to identify sector trends and investment opportunities.

In total, this means £1 billion of new funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors.

The Life Sciences Investment Programme will have access to a scientific advisory panel composed of leading industry figures, chaired by Life Sciences Champion Professor Sir John Bell. The panel will share insight on key scientific trends.

[1] https://bit.ly/3AQBc46

Image credits: James Newcombe / Unsplash and Sir John Bell
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Ovarian aging – it’s time to menopause for thought

It's World Menopause Day – time to focus on the future of ovarian longevity, not dwell in the present. World Menopause Day is held every...

New webinar set to raise profile of ovarian longevity

Up and ova: we're putting ovarian aging – what it is and why it's so very important to longevity – centre stage with a...

Longevity medicine course launches for UK doctors

Popular longevity medicine course launches for UK physicians on Health Data Research UK Platform. The first and now CME accredited online course “The Introduction to...

The three pillars for success in aging in place

Metabesity 2021: Eric Kihlstrom explains why design, language and business model are key factors for aging in place and the longevity ecosystem. Next week sees...